Wolverine Asset Management LLC Exelixis, Inc. Transaction History

Wolverine Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$20.53 - $25.22 $15,151 - $18,612	-738 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $13,571 - $18,302	738 New	738 $14,000
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $1,777 - $2,316	-86 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $1,415 - $2,358	86 New	86 $2,000
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $332 - $501	-23 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $30,502 - $43,052	-1,922 Reduced 98.82%	23 $0
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $8,926 - $12,851	403 Added 26.13%	1,945 $43,000
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $338,880 - $432,586	-13,986 Reduced 90.07%	1,542 $46,000
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $98,256 - $123,041	4,208 Added 37.17%	15,528 $376,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,320	11,320 $278,000

507

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.